@NP	Olfactory ensheathing	1
@NP	cells but not fibroblasts	23
@NP	the duration	56
@NP	autonomic dysreflexia	72
@NP	spinal cord injured rats a b s t r a c t Autonomic dysreflexia	97
@NP	spinal cord	97
@NP	rats a b s t r a c t Autonomic dysreflexia	117
@NP	rats	117
@NP	a b	124
@NP	t r a c t Autonomic dysreflexia	130
@NP	t r	130
@NP	a c t Autonomic dysreflexia	134
@NP	a common complication after high level spinal cord injury	165
@NP	a common complication	165
@NP	high level spinal cord injury	193
@NP	Wehave	252
@NP	the acute transplantation	281
@NP	olfactory ensheathing cells	310
@NP	the lesion site of rats transected at the fourth thoracic spinal cord level	343
@NP	the lesion site	343
@NP	rats transected at the fourth thoracic spinal cord level	362
@NP	rats	362
@NP	the fourth thoracic spinal cord level	381
@NP	autonomic dysreflexia	427
@NP	up to 8 weeks	449
@NP	spinal cord injury	469
@NP	This beneficial effect	489
@NP	changes in the morphology of sympathetic preganglionic neurons	532
@NP	changes	532
@NP	the morphology of sympathetic preganglionic neurons	543
@NP	the morphology	543
@NP	sympathetic preganglionic neurons	561
@NP	the olfactory cells	603
@NP	than 3 weeks	643
@NP	the transitory presence of olfactory ensheathing cells at the injury site	662
@NP	the transitory presence	662
@NP	olfactory ensheathing cells at the injury site	689
@NP	olfactory ensheathing cells	689
@NP	the injury site	720
@NP	long-termfunctional aswell asmorphological changes	746
@NP	the sympathetic preganglionic neurons	800
@NP	The primary aim of the present study	839
@NP	The primary aim	839
@NP	the present study	858
@NP	olfactory ensheathing cells	900
@NP	transplantation within the parenchyma close	942
@NP	transplantation	942
@NP	the parenchyma close	965
@NP	sympathetic preganglionic neurons	989
@NP	this position	1039
@NP	they	1054
@NP	the duration of autonomic dysreflexia	1072
@NP	the duration	1072
@NP	autonomic dysreflexia	1088
@NP	sympathetic preganglionic neuronmorphology	1123
@NP	The second aim	1167
@NP	the density of synapses on the somata of sympathetic preganglionic neurons	1198
@NP	the density	1198
@NP	synapses on the somata of sympathetic preganglionic neurons	1213
@NP	synapses	1213
@NP	the somata of sympathetic preganglionic neurons	1225
@NP	the somata	1225
@NP	sympathetic preganglionic neurons	1239
@NP	the hypothesis	1278
@NP	the reduction of autonomic dysreflexia	1298
@NP	the reduction	1298
@NP	autonomic dysreflexia	1315
@NP	synaptic changes	1346
@NP	a third aim	1367
@NP	we	1380
@NP	the cell type-specificity of olfactory ensheathing cells	1393
@NP	the cell type-specificity	1393
@NP	olfactory ensheathing cells	1422
@NP	their effects	1463
@NP	a control group transplanted with fibroblasts	1482
@NP	a control group	1482
@NP	fibroblasts	1516
@NP	Animals transplanted with OECs	1529
@NP	Animals	1529
@NP	OECs	1555
@NP	a faster recovery	1564
@NP	hypertension	1587
@NP	colorectal distension	1611
@NP	6 and 7 weeks	1636
@NP	8 weeks	1661
@NP	T4 spinal cord transection	1675
@NP	Olfactory ensheathing cells	1703
@NP	at least 8 weeks	1744
@NP	sympathetic preganglionic neurons	1791
@NP	whose overall number	1825
@NP	primary dendrites	1849
@NP	the synaptic density on the somata	1883
@NP	the synaptic density	1883
@NP	the somata	1907
@NP	both caudal to the lesion site.Our	1929
@NP	the lesion	1944
@NP	a long termcell	1979
@NP	type-specific effects of olfactory ensheathing cells	1995
@NP	type-specific effects	1995
@NP	olfactory ensheathing cells	2020
@NP	sympathetic preganglionic neurons morphology	2051
@NP	the synaptic density	2103
@NP	their somata	2127
@NP	a transient cell	2145
@NP	type-specific reduction of autonomic dysreflexia	2162
@NP	type-specific reduction	2162
@NP	autonomic dysreflexia	2189
@NP	Introduction Cardiovascular disorders after spinal cord injury	2215
@NP	Introduction Cardiovascular disorders	2215
@NP	spinal cord injury	2259
@NP	a leading cause	2288
@NP	morbidity and mortality	2307
@NP	spinal cord	2334
@NP	individuals	2354
@NP	Garshick et al. , 2005 ; Myers et al. , 2007 ; Soden et al. , 2000	2367
@NP	Garshick	2367
@NP	et al. , 2005 ; Myers et al. , 2007 ; Soden et al. , 2000	2376
@NP	et al. , 2005	2376
@NP	et al.	2376
@NP	2005	2384
@NP	Myers et al. , 2007	2390
@NP	Myers	2390
@NP	et al. , 2007	2396
@NP	et al.	2396
@NP	2007	2404
@NP	Soden et al. , 2000	2410
@NP	Soden	2410
@NP	et al. , 2000	2416
@NP	et al.	2416
@NP	2000	2424
@NP	particular clinical relevance	2434
@NP	autonomic dysreflexia which is characterized by a sudden	2467
@NP	autonomic dysreflexia	2467
@NP	a sudden	2515
@NP	massive	2528
@NP	discharge of sympathetic preganglionic neurons	2548
@NP	discharge	2548
@NP	sympathetic preganglionic neurons	2561
@NP	the injury site leading to extremely high arterial blood pressure	2601
@NP	the injury site	2601
@NP	extremely high arterial blood pressure	2628
@NP	Untreated episodes of autonomic dysreflexia	2668
@NP	Untreated episodes	2668
@NP	autonomic dysreflexia	2690
@NP	serious consequences	2721
@NP	epileptic seizures	2752
@NP	retinal detachment	2772
@NP	stroke	2792
@NP	even death , reviewed in -LRB- Wan et al. , 2014 -RRB-	2803
@NP	even death	2803
@NP	Wan et al. , 2014	2828
@NP	Wan	2828
@NP	et al.	2832
@NP	2014	2840
@NP	Olfactory ensheathing cells -LRB- OECs -RRB-	2847
@NP	Olfactory ensheathing cells	2847
@NP	OECs	2876
@NP	one of themost promising candidates	2892
@NP	one	2892
@NP	themost promising candidates	2899
@NP	cell-mediated repair following spinal cord injury	2932
@NP	cell-mediated repair	2932
@NP	spinal cord injury	2963
@NP	variability in replication	2991
@NP	variability	2991
@NP	replication	3006
@NP	numerous studies	3019
@NP	OECs	3052
@NP	awide range of beneficial effects	3069
@NP	awide range	3069
@NP	beneficial effects	3084
@NP	neural repair	3113
@NP	tissue sparing , neuroprotection ,	3128
@NP	tissue sparing	3128
@NP	neuroprotection	3144
@NP	cavity formation	3172
@NP	modification	3189
@NP	the glial scar , angiogenesis and remyelination of demyelinated axons	3205
@NP	the glial scar , angiogenesis and remyelination	3205
@NP	axons	3268
@NP	Franssen	3275
@NP	et al. , 2007	3284
@NP	et al.	3284
@NP	2007	3292
@NP	Mackay-Sim et al. , 2011	3298
@NP	Mackay-Sim	3298
@NP	et al. , 2011	3309
@NP	et al.	3309
@NP	2011	3317
@NP	Raisman et al. , 2012	3323
@NP	Raisman	3323
@NP	et al. , 2012	3331
@NP	et al.	3331
@NP	2012	3339
@NP	Raisman et al. , 2007	3345
@NP	Raisman	3345
@NP	et al. , 2007	3353
@NP	et al.	3353
@NP	2007	3361
@NP	Richter et al. , 2008	3367
@NP	Richter	3367
@NP	et al. , 2008	3375
@NP	et al.	3375
@NP	2008	3383
@NP	Roet et al. , 2014	3389
@NP	Roet	3389
@NP	et al. , 2014	3394
@NP	et al.	3394
@NP	2014	3402
@NP	Yang et al. , 2015	3408
@NP	Yang	3408
@NP	et al. , 2015	3413
@NP	et al.	3413
@NP	2015	3421
@NP	OEC transplantation	3428
@NP	a rat model	3471
@NP	autonomic dysreflexia	3486
@NP	spinal cord transection	3523
@NP	the fourth thoracic spinal cord level -LRB- T4 -RRB-	3550
@NP	the fourth thoracic spinal cord level	3550
@NP	T4	3589
@NP	Kalincik	3594
@NP	et al. , 2010a	3603
@NP	et al.	3603
@NP	2010a	3611
@NP	Acute transplantation of OECs at the lesion site	3619
@NP	Acute transplantation	3619
@NP	OECs at the lesion site	3644
@NP	OECs	3644
@NP	the lesion site	3652
@NP	the duration of autonomic dysreflexia	3676
@NP	the duration	3676
@NP	autonomic dysreflexia	3692
@NP	the morphology of spinal cord	3726
@NP	the morphology	3726
@NP	spinal cord	3744
@NP	sympathetic preganglionic neurons	3756
@NP	a crucial role	3800
@NP	central cardiovascular control	3818
@NP	Cabot	3850
@NP	1996 ; Calaresu et al. , 1988 ; Chalmers et al. , 1991 ; Reis et al.	3857
@NP	1996	3857
@NP	Calaresu et al. , 1988 ; Chalmers et al. , 1991 ; Reis et al.	3863
@NP	Calaresu et al. , 1988	3863
@NP	Calaresu et al.	3863
@NP	1988	3880
@NP	Chalmers et al. , 1991	3886
@NP	Chalmers	3886
@NP	et al. , 1991	3895
@NP	et al.	3895
@NP	1991	3903
@NP	Reis et al.	3909
@NP	Reis	3909
@NP	et al.	3914
@NP	1988	3922
@NP	These sympathetic preganglionic neurons	3929
@NP	autonomic dysreflexia	4000
@NP	the T4-transected rat model -LRB- Leman et al. , 2002 -RRB-	4025
@NP	the T4-transected rat model	4025
@NP	Leman	4054
@NP	et al. , 2002	4060
@NP	et al.	4060
@NP	2002	4068
@NP	T4 spinal cord transection	4081
@NP	there	4108
@NP	a sustained increase	4118
@NP	soma size	4142
@NP	sympathetic preganglionic neurons	4155
@NP	a temporary increase in the number	4194
@NP	a temporary increase	4194
@NP	the number	4218
@NP	lengths of their primary dendrites -LRB- Kalincik et al. , 2010b -RRB-	4233
@NP	lengths	4233
@NP	their primary dendrites -LRB- Kalincik et al. , 2010b -RRB-	4244
@NP	their primary dendrites	4244
@NP	Kalincik	4269
@NP	et al. , 2010b	4278
@NP	et al.	4278
@NP	2010b	4286
@NP	OEC transplantation into the lesion site	4294
@NP	OEC transplantation	4294
@NP	the lesion site	4319
@NP	the changes	4346
@NP	soma size of the sympathetic preganglionic neurons belowthe lesion	4361
@NP	soma size	4361
@NP	the sympathetic preganglionic neurons belowthe lesion	4374
@NP	the lengths of dendrites in the sympathetic preganglionic neurons	4446
@NP	the lengths	4446
@NP	dendrites in the sympathetic preganglionic neurons	4461
@NP	dendrites	4461
@NP	the sympathetic preganglionic neurons	4474
@NP	the lesion -LRB- Kalincik et al. , 2010a ; Kalincik et al. , 2010b -RRB-	4518
@NP	the lesion	4518
@NP	Kalincik	4530
@NP	et al. , 2010a ; Kalincik et al. , 2010b	4539
@NP	et al.	4539
@NP	2010a ; Kalincik et al.	4547
@NP	2010a	4547
@NP	Kalincik et al.	4554
@NP	Kalincik	4554
@NP	et al.	4563
@NP	2010b	4571
@NP	These increases in soma sizes	4579
@NP	These increases	4579
@NP	soma sizes	4598
@NP	9 weeks	4623
@NP	OEC transplantation	4637
@NP	the increases in dendrite number and length	4661
@NP	the increases	4661
@NP	dendrite number and length	4678
@NP	only temporary -LRB- Kalincik et al. , 2010b -RRB-	4710
@NP	only temporary	4710
@NP	Kalincik	4726
@NP	et al. , 2010b	4735
@NP	et al.	4735
@NP	2010b	4743
@NP	these experiments	4755
@NP	the OECswere	4773
@NP	the lesion site	4804
@NP	the spinal cord transection	4838
@NP	The OECs	4867
@NP	no N3 weeks	4885
@NP	the transitory presence of OECs at the injury site	4913
@NP	the transitory presence	4913
@NP	OECs at the injury site	4940
@NP	OECs	4940
@NP	the injury site	4948
@NP	long-term functional as well as morphological changes	4974
@NP	This outcome	5029
@NP	the transplanted OECs	5069
@NP	example	5116
@NP	them	5141
@NP	the spinal cord	5151
@NP	the lesion site	5179
@NP	its epicenter -LRB- Pearse et al. , 2007 -RRB-	5208
@NP	its epicenter	5208
@NP	Pearse	5223
@NP	et al. , 2007	5230
@NP	et al.	5230
@NP	2007	5238
@NP	The first aim	5245
@NP	OECs	5302
@NP	transplantation within the parenchyma close	5321
@NP	transplantation	5321
@NP	the parenchyma close	5344
@NP	sympathetic preganglionic neurons	5368
@NP	this position	5418
@NP	they	5433
@NP	the duration of autonomic dysreflexia	5451
@NP	the duration	5451
@NP	autonomic dysreflexia	5467
@NP	sympathetic preganglionic neuron morphology	5502
@NP	The severity	5547
@NP	attacks of autonomic dysreflexia after T4/5 spinal cord transection	5563
@NP	attacks	5563
@NP	autonomic dysreflexia after T4/5 spinal cord transection	5574
@NP	autonomic dysreflexia	5574
@NP	T4/5 spinal cord transection	5602
@NP	a reorganization	5654
@NP	synaptic circuitry	5674
@NP	the activity	5705
@NP	sympathetic preganglionic neurons	5721
@NP	Llewellyn-Smith	5756
@NP	2009 ; Maiorov et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al.	5773
@NP	2009	5773
@NP	Maiorov et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al.	5779
@NP	Maiorov	5779
@NP	et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al.	5787
@NP	et al. , 1997a	5787
@NP	et al.	5787
@NP	1997a	5795
@NP	Maiorov et al. , 1997b	5802
@NP	Maiorov	5802
@NP	et al. , 1997b	5810
@NP	et al.	5810
@NP	1997b	5818
@NP	Marsh et al.	5825
@NP	Marsh	5825
@NP	et al.	5831
@NP	2004	5839
@NP	the reduction in severity of autonomic dysreflexia by OEC transplantation	5856
@NP	the reduction	5856
@NP	severity of autonomic dysreflexia by OEC transplantation	5873
@NP	severity	5873
@NP	autonomic dysreflexia by OEC transplantation	5885
@NP	autonomic dysreflexia	5885
@NP	OEC transplantation	5910
@NP	a reorganization in synaptic inputs	5942
@NP	a reorganization	5942
@NP	synaptic inputs	5962
@NP	changes in the morphology of sympathetic preganglionic neurons	5989
@NP	changes	5989
@NP	the morphology of sympathetic preganglionic neurons	6000
@NP	the morphology	6000
@NP	sympathetic preganglionic neurons	6018
@NP	The second aim of the present study	6053
@NP	The second aim	6053
@NP	the present study	6071
@NP	the density of synapses on the somata of sympathetic preganglionic neurons	6105
@NP	the density	6105
@NP	synapses on the somata of sympathetic preganglionic neurons	6120
@NP	synapses	6120
@NP	the somata of sympathetic preganglionic neurons	6132
@NP	the somata	6132
@NP	sympathetic preganglionic neurons	6146
@NP	OEC transplantation	6186
@NP	the hypothesis	6211
@NP	the reduction of autonomic dysreflexia	6231
@NP	the reduction	6231
@NP	autonomic dysreflexia	6248
@NP	synaptic changes	6279
@NP	the morphologic changes	6307
@NP	Kalincik	6355
@NP	et al. , 2010a ; Kalincik et al. , 2010b	6364
@NP	et al.	6364
@NP	2010a ; Kalincik et al.	6372
@NP	2010a	6372
@NP	Kalincik et al.	6379
@NP	Kalincik	6379
@NP	et al.	6388
@NP	2010b	6396
@NP	Previous studies	6404
@NP	the cell type-specificity effects of olfactory ensheathing cells	6439
@NP	the cell type-specificity effects	6439
@NP	olfactory ensheathing cells	6476
@NP	them	6517
@NP	a fibroblasts	6527
@NP	transplanted group	6541
@NP	a control -LRB- Khankan et al. , 2016 ; Toft et al. , 2013 -RRB-	6563
@NP	a control	6563
@NP	Khankan	6574
@NP	et al. , 2016 ; Toft et al. , 2013	6582
@NP	et al.	6582
@NP	2016 ; Toft et al.	6590
@NP	2016	6590
@NP	Toft et al.	6596
@NP	Toft	6596
@NP	et al.	6601
@NP	2013	6609
@NP	a third aim	6619
@NP	we	6632
@NP	the changes	6658
@NP	autonomic dysreflexia	6673
@NP	sympathetic preganglionic neurons morphology	6696
@NP	the density	6745
@NP	synapses on the somata of sympathetic preganglionic neuronswere	6760
@NP	synapses	6760
@NP	the somata of sympathetic preganglionic neuronswere	6772
@NP	the somata	6772
@NP	sympathetic preganglionic neuronswere	6786
@NP	olfactory ensheathing cells	6836
@NP	fibroblasts -LRB- control group -RRB-	6883
@NP	fibroblasts	6883
@NP	control group	6896
@NP	response	6928
@NP	cell transplantation	6940
@NP	Materials andmethods 2.1 .	6966
@NP	Materials andmethods	6966
@NP	2.1	6987
@NP	Animals Experiments	6992
@NP	24 adult male Australian inbred Wistar rats	7030
@NP	Biological Resource Centre , Sydney , New South Wales	7075
@NP	Biological Resource Centre	7075
@NP	Sydney	7103
@NP	New South Wales	7111
@NP	350 -- 400 g	7129
@NP	350	7129
@NP	400 g	7133
@NP	They	7141
@NP	65 × 40 × 22 cm	7192
@NP	65 × 40 ×	7192
@NP	65 ×	7192
@NP	40 ×	7197
@NP	22 cm	7202
@NP	ad libitum food	7214
@NP	a 12/12 h light/dark cycle	7258
@NP	All experimental procedures	7286
@NP	the Animal Care and Ethics Committees	7331
@NP	the University of New South Wales and Griffith University in accordance	7372
@NP	the University	7372
@NP	New South Wales and Griffith University in accordance	7390
@NP	New South Wales and Griffith University	7390
@NP	accordance	7433
@NP	guidelines of the National Health and Medical Research Council of Australia	7449
@NP	guidelines of the National Health	7449
@NP	guidelines	7449
@NP	the National Health	7463
@NP	Medical Research Council of Australia	7487
@NP	Medical Research Council	7487
@NP	Australia	7515
@NP	2.2	7526
@NP	Biopsy and culture	7531
@NP	olfactory ensheathing cells and fibroblasts	7553
@NP	Six adult male albino Australian inbred Wistar rats	7597
@NP	Biological Resource Centre , Sydney , New South Wales	7650
@NP	Biological Resource Centre	7650
@NP	Sydney	7678
@NP	New South Wales	7686
@NP	350 -- 400 g	7704
@NP	350	7704
@NP	400 g	7708
@NP	harvesting and culture of OECs and fibroblasts	7729
@NP	harvesting and culture	7729
@NP	OECs and fibroblasts	7755
@NP	These rats	7777
@NP	pentobarbitone -LRB- 0.5 ml intraperitoneally	7819
@NP	pentobarbitone	7819
@NP	0.5 ml	7835
@NP	Lethabarb	7861
@NP	Virbac Pty.	7872
@NP	Ltd. , NSW , Australia -RRB-	7884
@NP	Ltd.	7884
@NP	NSW	7890
@NP	Australia	7895
@NP	decapitation	7920
@NP	OECswere	7934
@NP	fromthe olfactory mucosa	7952
@NP	rats in the samemanner as previously described -LRB- Bianco et al. , 2004 -RRB-	7980
@NP	rats	7980
@NP	the samemanner as previously described -LRB- Bianco et al. , 2004 -RRB-	7988
@NP	the samemanner	7988
@NP	Bianco	8028
@NP	et al. , 2004	8035
@NP	et al.	8035
@NP	2004	8043
@NP	Isolation and purification of the OECS	8050
@NP	Isolation and purification	8050
@NP	the OECS	8080
@NP	the same manner as previously described -LRB- Kalincik et al. , 2010a -RRB-	8107
@NP	the same manner	8107
@NP	Kalincik	8148
@NP	et al. , 2010a	8157
@NP	et al.	8157
@NP	2010a	8165
@NP	Primary cultures of fibroblasts from the same strain of rat	8173
@NP	Primary cultures	8173
@NP	fibroblasts from the same strain of rat	8193
@NP	fibroblasts	8193
@NP	the same strain of rat	8210
@NP	the same strain	8210
@NP	rat	8229
@NP	skin biopsies	8253
@NP	published protocol -LRB- Matigian et al. , 2008 -RRB-	8280
@NP	published protocol	8280
@NP	Matigian	8300
@NP	et al. , 2008	8309
@NP	et al.	8309
@NP	2008	8317
@NP	Only OECs	8324
@NP	humanised Renilla	8359
@NP	green fluorescent protein	8377
@NP	Gorrie	8428
@NP	et al. , 2010	8435
@NP	et al.	8435
@NP	2010	8443
@NP	OECs and fibroblasts	8450
@NP	tissue culture flasks as described previously -LRB- Gorrie et al. , 2010 -RRB-	8495
@NP	tissue culture flasks	8495
@NP	Gorrie	8542
@NP	et al. , 2010	8549
@NP	et al.	8549
@NP	2010	8557
@NP	2.3	8564
@NP	Spinal cord transection and cell transplantation	8569
@NP	Eighteen ratswere anaesthetisedwith	8618
@NP	a mixture of ketamine hydrochloride -LRB- 100 mg kg − 1 intraperitoneally	8654
@NP	a mixture	8654
@NP	ketamine hydrochloride -LRB- 100 mg kg − 1 intraperitoneally	8667
@NP	ketamine hydrochloride -LRB- 100 mg kg − 1	8667
@NP	ketamine hydrochloride	8667
@NP	100 mg kg − 1	8691
@NP	100 mg kg −	8691
@NP	1	8701
@NP	Ketamine , Parnell Laboratories Pty.	8722
@NP	Ketamine	8722
@NP	Parnell Laboratories Pty.	8732
@NP	Ltd. , NSW , Australia -RRB- and xylazine -LRB- 7 mg kg − 1 , intraperitoneally	8758
@NP	Ltd. , NSW , Australia -RRB-	8758
@NP	Ltd.	8758
@NP	NSW	8764
@NP	Australia	8769
@NP	xylazine -LRB- 7 mg kg − 1 , intraperitoneally	8784
@NP	xylazine	8784
@NP	7 mg kg − 1 , intraperitoneally	8794
@NP	7 mg kg −	8794
@NP	1	8802
@NP	Ilium Xylazil-20 , Troy Laboratories Pty.	8824
@NP	Ilium Xylazil-20	8824
@NP	Troy Laboratories Pty.	8842
@NP	Ltd. , NSW , Australia -RRB- .	8865
@NP	Ltd. , NSW , Australia -RRB-	8865
@NP	Ltd.	8865
@NP	NSW , Australia -RRB-	8871
@NP	NSW	8871
@NP	Laminectomy of the T3 vertebra	8888
@NP	Laminectomy	8888
@NP	the T3 vertebra	8903
@NP	the T4 spinal segment	8943
@NP	Kalincik	8992
@NP	et al. , 2010a	9001
@NP	et al.	9001
@NP	2010a	9009
@NP	immobilization of the spinal process rostral to the laminectomy site	9023
@NP	immobilization	9023
@NP	the spinal process rostral to the laminectomy site	9041
@NP	the spinal process rostral	9041
@NP	the laminectomy site	9071
@NP	GFP-OECs -LRB- n = 9 animals -RRB-	9093
@NP	GFP-OECs	9093
@NP	n	9103
@NP	9 animals	9107
@NP	a sterile 10 μl Hamilton syringe -LRB- Hamilton , Reno , NV -RRB-	9154
@NP	a sterile 10 μl Hamilton syringe	9154
@NP	10 μl	9164
@NP	Hamilton	9188
@NP	Reno	9198
@NP	NV	9204
@NP	a silicon-coated	9213
@NP	glass tip	9237
@NP	inner diameter of 80 -- 100 μm	9253
@NP	inner diameter of 80	9253
@NP	inner diameter	9253
@NP	80	9271
@NP	100 μm	9275
@NP	Rats -LRB- n = 9 -RRB-	9284
@NP	Rats	9284
@NP	n	9290
@NP	9	9294
@NP	four injections	9306
@NP	GFP-OECs -LRB- 0.5 μl of 100,000 cells/μl , in culture medium DMEM/F12 -RRB-	9325
@NP	GFP-OECs	9325
@NP	0.5 μl of 100,000 cells/μl , in culture medium DMEM/F12	9335
@NP	0.5 μl	9335
@NP	100,000 cells/μl	9345
@NP	culture medium DMEM/F12	9366
@NP	two injections 2 mm cranial	9392
@NP	two injections	9392
@NP	2 mm cranial	9407
@NP	two 2 mm caudal to the future lesion site , each 0.5 mm lateral	9424
@NP	two 2 mm caudal	9424
@NP	the future lesion site , each 0.5 mm lateral	9443
@NP	the future lesion site	9443
@NP	each 0.5 mm lateral	9467
@NP	the midline	9490
@NP	0.8 mm	9505
@NP	each injection	9522
@NP	the needle	9538
@NP	situ for 1	9561
@NP	situ	9561
@NP	1	9570
@NP	2 min	9572
@NP	reflux	9589
@NP	Control animals -LRB- n = 9 -RRB-	9597
@NP	Control animals	9597
@NP	n	9614
@NP	9	9618
@NP	fibroblasts	9630
@NP	similar concentrations	9645
@NP	The spinal cord	9669
@NP	microscissors between the two pairs of injection sites	9721
@NP	microscissors	9721
@NP	the two pairs of injection sites	9743
@NP	the two pairs	9743
@NP	injection sites	9760
@NP	Complete transection	9777
@NP	a scalpel blade and observation	9817
@NP	a scalpel blade	9817
@NP	observation	9837
@NP	the dissecting microscope	9855
@NP	transection , a gap of approximately 1	9892
@NP	transection	9892
@NP	a gap of approximately 1	9905
@NP	a gap	9905
@NP	approximately 1	9914
@NP	2 mm	9930
@NP	the rostral and caudal ends of the cord	9955
@NP	the rostral and caudal ends	9955
@NP	the cord	9986
@NP	a piece	9999
@NP	absorbable gelatin sponge	10010
@NP	SPONGOSTAN ® , Johnson and Johnson medical limited , Sipton , U.K.	10037
@NP	SPONGOSTAN ®	10037
@NP	Johnson	10050
@NP	Johnson medical limited , Sipton , U.K.	10062
@NP	Johnson medical limited , Sipton ,	10062
@NP	U.K.	10095
@NP	the gap	10122
@NP	bleeding	10141
@NP	Another piece of absorbable gelatin sponge	10151
@NP	Another piece	10151
@NP	absorbable gelatin sponge	10168
@NP	the dorsal surface of the cord	10213
@NP	the dorsal surface	10213
@NP	the cord	10235
@NP	the muscle tissue and skin	10248
@NP	layers	10291
@NP	surgery	10317
@NP	the rats	10326
@NP	the muscarinic cholinoceptor antagonist atropine methyl nitrate	10344
@NP	3 mg kg − 1 subcutaneously	10409
@NP	3 mg kg −	10409
@NP	1 subcutaneously	10417
@NP	1	10417
@NP	Sigma , St.	10435
@NP	Louis , MO , USA -RRB- .	10446
@NP	Louis	10446
@NP	USA	10457
@NP	An antibiotic	10463
@NP	Cephalothin , 30 mg kg − 1 subcutaneously ; VIC , Australia	10478
@NP	Cephalothin	10478
@NP	30 mg kg − 1 subcutaneously ; VIC	10491
@NP	30 mg kg − 1 subcutaneously	10491
@NP	30 mg kg −	10491
@NP	1 subcutaneously	10500
@NP	1	10500
@NP	VIC	10518
@NP	Australia	10523
@NP	there	10574
@NP	no sign	10584
@NP	urinary infection	10595
@NP	cloudiness of expressed urine	10623
@NP	cloudiness	10623
@NP	expressed urine	10637
@NP	three consecutive days	10658
@NP	Animals	10682
@NP	an analgesic -LRB- Carprofen , 50 mg kg − 1 subcutaneously ; Australia Pty.	10704
@NP	an analgesic -LRB- Carprofen , 50 mg kg − 1 subcutaneously	10704
@NP	an analgesic -LRB- Carprofen , 50 mg kg −	10704
@NP	Carprofen	10718
@NP	50 mg	10729
@NP	1	10738
@NP	Australia Pty.	10756
@NP	Ltd. , Australia -RRB- daily for 2 -- 3 days .	10771
@NP	Ltd. , Australia -RRB- daily for 2	10771
@NP	Ltd. , Australia -RRB-	10771
@NP	Ltd.	10771
@NP	2	10798
@NP	3 days	10800
@NP	Lactated Hartmann 's solution -LRB- 5 -- 10 ml subcutaneously	10808
@NP	Lactated Hartmann 's	10808
@NP	solution -LRB- 5 -- 10 ml subcutaneously	10828
@NP	solution	10828
@NP	5 -- 10 ml subcutaneously	10838
@NP	5 -- 10	10838
@NP	ml subcutaneously	10843
@NP	ml	10843
@NP	Baxter Healthcare Pty.	10862
@NP	Ltd.	10885
@NP	Sydney	10890
@NP	Australia	10898
@NP	2 -- 3 times daily until the rats were able to drink normally	10926
@NP	2	10926
@NP	3 times	10928
@NP	the rats	10948
@NP	Manual emptying of the urinary bladder	10986
@NP	Manual emptying	10986
@NP	the urinary bladder	11005
@NP	3 times a day	11041
@NP	3 times	11041
@NP	a day	11049
@NP	the rats	11061
@NP	a micturition reflex -LRB- ~ 2 weeks -RRB-	11080
@NP	a micturition reflex	11080
@NP	~ 2 weeks	11102
@NP	~	11102
@NP	2 weeks	11103
@NP	The room temperature	11113
@NP	27 -- 28 °C for the first 1	11152
@NP	27	11152
@NP	28 °C for the first 1	11155
@NP	28 °C	11155
@NP	the first 1	11165
@NP	2 weeks and rat core temperature	11177
@NP	2 weeks	11177
@NP	rat core temperature	11189
@NP	normal temperature	11239
@NP	The room temperature	11274
@NP	26 °C	11313
@NP	the end of the experiment	11325
@NP	the end	11325
@NP	the experiment	11336
@NP	2.4	11352
@NP	Implantation	11357
@NP	radio-telemetric probes Four weeks after spinal cord transection , the rats	11373
@NP	radio-telemetric probes	11373
@NP	Four weeks	11397
@NP	spinal cord transection , the rats	11414
@NP	spinal cord transection	11414
@NP	the rats	11439
@NP	radio-telemetric probes -LRB- PA-C40 , Data Sciences	11480
@NP	radio-telemetric probes	11480
@NP	PA-C40	11505
@NP	Data Sciences	11513
@NP	International St.	11527
@NP	Paul , MN , USA .	11545
@NP	Paul	11545
@NP	MN	11551
@NP	USA .	11555
@NP	the measurement	11565
@NP	the mean	11584
@NP	arterial pressure and heart rate	11593
@NP	Cloutier	11651
@NP	et al. , 2010	11660
@NP	et al.	11660
@NP	2010	11668
@NP	2.5	11675
@NP	Induction of autonomic dysreflexia	11680
@NP	Induction	11680
@NP	autonomic dysreflexia	11693
@NP	Colorectal distensions	11715
@NP	6 , 7 and 8	11758
@NP	weeks	11769
@NP	the spinal cord injury	11781
@NP	Kalincik et al. , 2010a	11843
@NP	Kalincik	11843
@NP	et al.	11852
@NP	2010a	11860
@NP	The average response	11868
@NP	three distensions made during the recording period	11909
@NP	three distensions	11909
@NP	the recording period	11939
@NP	The entire cardiovascular response	11961
@NP	colorectal distensions	11999
@NP	a 10 min period following the distension	12033
@NP	a 10 min period	12033
@NP	the distension	12059
@NP	the average peak changes in mean arterial pressure and heart rate	12092
@NP	the average peak changes	12092
@NP	mean arterial pressure and heart rate	12120
@NP	2.6	12175
@NP	Radio-telemetric recording	12180
@NP	At least half an hour	12207
@NP	At least half	12207
@NP	an hour	12221
@NP	recording	12238
@NP	cardiovascular parameters	12256
@NP	colorectal distension responses , radio-telemetric probes	12286
@NP	colorectal distension responses	12286
@NP	radio-telemetric probes	12319
@NP	Mean arterial pressure and heart rate	12359
@NP	Mean arterial pressure	12359
@NP	heart rate	12386
@NP	3 s	12416
@NP	every 10 s via a data acquisition package -LRB- Dataquest ART ,	12420
@NP	every 10 s via a data acquisition package	12420
@NP	every 10 s	12420
@NP	a data acquisition package	12435
@NP	Dataquest ART	12463
@NP	Data Sciences International St.	12478
@NP	Paul , MN , USA -RRB- .	12510
@NP	Paul , MN , USA -RRB-	12510
@NP	Paul	12510
@NP	MN , USA -RRB-	12516
@NP	MN	12516
@NP	Resting cardiovascular parameters	12526
@NP	a 20 min period	12579
@NP	rats	12602
@NP	rest in their home cage	12615
@NP	rest	12615
@NP	their home cage	12623
@NP	The average mean arterial pressure and heart rate for each rat	12640
@NP	The average mean arterial pressure	12640
@NP	heart rate for each rat	12679
@NP	heart rate	12679
@NP	each rat	12694
@NP	the entire 20 min period	12728
@NP	comparison , resting cardiovascular parameters	12758
@NP	comparison	12758
@NP	cardiovascular parameters	12778
@NP	arterial pressure and heart rate	12810
@NP	arterial pressure	12810
@NP	heart rate	12832
@NP	a group of 6 adult male AAWrats	12861
@NP	a group	12861
@NP	6 adult male AAWrats	12872
@NP	spinal cord injury	12901
@NP	Colorectal distensions response recordings	12921
@NP	the experimental animals with the same settings	12979
@NP	the experimental animals	12979
@NP	the same settings	13009
@NP	Histochemistry , immunofluorescence and image analysis	13619
@NP	Nineweeks	13673
@NP	cell transplantation	13689
@NP	anaesthesiawith	13717
@NP	a combination	13733
@NP	ketamine and xylazine	13750
@NP	radio-telemetric probes	13782
@NP	the femoral artery ligated	13823
@NP	the femoral artery	13823
@NP	Animalswere	13851
@NP	then	13863
@NP	terminally anaesthetizedwith sodiumpentobarbitone	13868
@NP	Nembutal ; 80mg/ml , IP	13919
@NP	Nembutal	13919
@NP	80mg/ml , IP	13929
@NP	80mg/ml	13929
@NP	IP	13938
@NP	50 ml	13975
@NP	physiological	13984
@NP	saline	14010
@NP	500 ml	14029
@NP	4 % paraformaldehyde -LRB- Fisher Scientific , Pittsburgh , PA , USA -RRB-	14039
@NP	4 % paraformaldehyde	14039
@NP	Fisher Scientific , Pittsburgh , PA , USA	14060
@NP	Fisher Scientific	14060
@NP	Pittsburgh	14079
@NP	PA	14091
@NP	USA	14095
@NP	0.1 M phosphate buffer pH 7.4	14103
@NP	0.1 M phosphate buffer	14103
@NP	pH 7.4	14126
@NP	Spinal cord regions	14134
@NP	1 cm above and 1 cm	14164
@NP	1 cm	14164
@NP	and 1 cm	14175
@NP	the injection/injury site	14190
@NP	post	14232
@NP	the same fixative overnight	14246
@NP	a solution of 30 % sucrose in 0.1 Mphosphate buffer	14300
@NP	a solution	14300
@NP	30 % sucrose in 0.1 Mphosphate buffer	14314
@NP	30 % sucrose	14314
@NP	0.1 Mphosphate buffer	14329
@NP	The spinal cords	14351
@NP	35 μm with a cryostat	14399
@NP	35 μm	14399
@NP	a cryostat	14410
@NP	gelatin-coated slides	14438
@NP	series of four	14463
@NP	series	14463
@NP	four	14473
@NP	− 22 °C	14503
@NP	NADPH-diaphorase staining of sympathetic preganglionic neurons	14511
@NP	NADPH-diaphorase staining	14511
@NP	sympathetic preganglionic neurons	14540
@NP	Carrive et al. , 1994 ; Kalincik et al. , 2010a ; Vincent et al. , 1992	14615
@NP	Carrive	14615
@NP	et al. , 1994 ; Kalincik et al. , 2010a ; Vincent et al. , 1992	14623
@NP	et al. , 1994	14623
@NP	et al.	14623
@NP	1994	14631
@NP	Kalincik et al. , 2010a	14637
@NP	Kalincik	14637
@NP	et al. , 2010a	14646
@NP	et al.	14646
@NP	2010a	14654
@NP	Vincent et al. , 1992	14661
@NP	Vincent	14661
@NP	et al. , 1992	14669
@NP	et al.	14669
@NP	1992	14677
@NP	immunofluorescence	14688
@NP	pretreatment with phosphate-buffered saline triton	14714
@NP	pretreatment	14714
@NP	phosphate-buffered saline triton	14732
@NP	cryostat sections	14766
@NP	4 °C	14812
@NP	primary antibodies	14821
@NP	goat anti-choline acetyltransferase	14840
@NP	1:100	14877
@NP	Chemicon , Temecula	14884
@NP	CA , USA	14904
@NP	rabbit anti-synaptophysin -LRB- 1:200 , Dako -RRB-	14917
@NP	rabbit anti-synaptophysin	14917
@NP	1:200	14944
@NP	Dako	14951
@NP	Donkey anti-goat and mouse antirabbit secondary antibodies	14958
@NP	Donkey anti-goat and mouse antirabbit	14958
@NP	Donkey	14958
@NP	anti-goat and mouse antirabbit	14965
@NP	Alexa Fluor	15018
@NP	488 or 594 , Molecular Probes , Eugene , OR , USA	15030
@NP	488 or 594	15030
@NP	Molecular Probes	15042
@NP	Eugene	15060
@NP	OR	15068
@NP	USA	15072
@NP	a dilution of 1:200	15090
@NP	a dilution	15090
@NP	1:200	15104
@NP	10 % normal goat serumin phosphate-buffered saline	15113
@NP	10 %	15113
@NP	2 h of incubation	15170
@NP	2 h	15170
@NP	incubation	15177
@NP	all sections	15189
@NP	phosphate-buffered saline	15217
@NP	5 min at room temperature in Hoechst solution	15261
@NP	5 min	15261
@NP	room temperature in Hoechst solution	15270
@NP	room temperature	15270
@NP	Hoechst solution	15290
@NP	1:5000 in phosphate-buffered saline	15308
@NP	1:5000	15308
@NP	phosphate-buffered saline	15318
@NP	Molecular Probes , Eugene , OR , USA	15345
@NP	Molecular Probes	15345
@NP	Eugene	15363
@NP	OR	15371
@NP	USA	15375
@NP	Standard immunohistochemical controls	15381
@NP	each run	15436
@NP	Images	15446
@NP	an Olympus FV1000 confocal microscope	15473
@NP	405 , 488 , 543 nm lasers and a UPLSAPO 60 × O objective	15525
@NP	405	15525
@NP	488	15530
@NP	543 nm lasers	15535
@NP	a UPLSAPO 60 × O objective	15553
@NP	a UPLSAPO	15553
@NP	60 × O objective	15563
@NP	a numerical aperture of 1.35	15584
@NP	a numerical aperture	15584
@NP	1.35	15608
@NP	Imaging variables	15614
@NP	laser power , pinhole , detector gain and dwell time	15633
@NP	laser power	15633
@NP	pinhole	15646
@NP	detector gain and dwell time	15655
@NP	all images	15708
@NP	Each image	15720
@NP	three fluorescent channels	15744
@NP	Red	15772
@NP	-LRB- anti-choline acetyltransferase ,	15776
@NP	the sympathetic preganglionic neurons	15821
@NP	green -LRB- anti-synaptophysin , to identify synaptic boutons -RRB-	15861
@NP	green	15861
@NP	anti-synaptophysin , to identify synaptic boutons	15868
@NP	anti-synaptophysin	15868
@NP	synaptic boutons	15900
@NP	blue -LRB- DAPI , to identify nuclei -RRB-	15922
@NP	blue	15922
@NP	DAPI , to identify nuclei	15928
@NP	DAPI	15928
@NP	nuclei	15946
@NP	3D optical sectioning through the tissue	15960
@NP	3D optical sectioning	15960
@NP	the tissue	15990
@NP	single optical sections	16002
@NP	sympathetic preganglionic neurons -LRB- red channel -RRB-	16029
@NP	sympathetic preganglionic neurons	16029
@NP	red channel	16064
@NP	the central plane of the nucleus -LRB- blue channel -RRB-	16109
@NP	the central plane	16109
@NP	the nucleus -LRB- blue channel -RRB-	16130
@NP	the nucleus	16130
@NP	blue channel	16143
@NP	the red cell	16173
@NP	the blue cell nucleus	16217
@NP	Basic Gaussian noise removal	16240
@NP	the red channel , followed by thresholding to produce a binary image	16291
@NP	the red channel	16291
@NP	a binary image	16344
@NP	Gaps in the red channel pixels that did not touch the border of the cell image	16360
@NP	Gaps	16360
@NP	the red channel pixels that did not touch the border of the cell image	16368
@NP	the red channel pixels	16368
@NP	the border of the cell image	16410
@NP	the border	16410
@NP	the cell image	16424
@NP	an initial cell mask	16461
@NP	a	16489
@NP	the initialmask	16509
@NP	a larger second cell mask	16548
@NP	the difference between the two masks	16580
@NP	the difference	16580
@NP	the two masks	16603
@NP	a 1.54 μm	16626
@NP	wide outline of the cell	16636
@NP	wide outline	16636
@NP	the cell	16652
@NP	This border	16662
@NP	cell area -LRB- μm2 -RRB-	16696
@NP	cell area	16696
@NP	μm2	16707
@NP	the number of synaptophysin positive pixels -LRB- green channel -RRB-	16725
@NP	the number	16725
@NP	synaptophysin positive pixels -LRB- green channel -RRB-	16739
@NP	synaptophysin positive pixels	16739
@NP	green channel	16770
@NP	2.8	16799
@NP	Morphometric analysis of sympathetic preganglionic neurons	16804
@NP	Morphometric analysis	16804
@NP	sympathetic preganglionic neurons	16829
@NP	sympathetic preganglionic neurons in the injured spinal cords	16889
@NP	sympathetic preganglionic neurons	16889
@NP	the injured spinal cords	16926
@NP	Kalincik et al. , 2010a	16982
@NP	Kalincik	16982
@NP	et al.	16991
@NP	2010a	16999
@NP	Nine	17007
@NP	ten sympathetic preganglionic neurons located rostrally -LRB- T2 -- T3 -RRB-	17015
@NP	ten sympathetic preganglionic neurons	17015
@NP	T2 -- T3	17072
@NP	T2	17072
@NP	T3	17075
@NP	9	17083
@NP	10 sympathetic preganglionic neurons	17085
@NP	T5 -- T6	17140
@NP	T5	17140
@NP	T6	17143
@NP	the injury site with clearly distinguishable perikarya	17150
@NP	the injury site	17150
@NP	clearly distinguishable perikarya	17171
@NP	dendritic treeswere selected	17209
@NP	dendritic treeswere	17209
@NP	Threemorphological featureswere selected for analysis	17239
@NP	Threemorphological featureswere	17239
@NP	analysis	17284
@NP	area	17294
@NP	soma , sum of lengths of all visible processes and number of primary dendrites	17302
@NP	soma	17302
@NP	sum of lengths of all visible processes	17308
@NP	sum	17308
@NP	lengths of all visible processes	17315
@NP	lengths	17315
@NP	all visible processes	17326
@NP	number of primary dendrites	17352
@NP	number	17352
@NP	primary dendrites	17362
@NP	These	17381
@NP	ImageJ software	17407
@NP	2.9	17424
@NP	Statistical analysis	17429
@NP	The software packages	17450
@NP	StatView 5.0 -LRB- SAS Institute , Cary , NC , USA -RRB-	17472
@NP	StatView 5.0	17472
@NP	SAS Institute	17486
@NP	Cary	17501
@NP	NC , USA	17507
@NP	Prism 6.0 -LRB- La Jolla , CAL , USA -RRB-	17517
@NP	Prism 6.0	17517
@NP	La Jolla	17528
@NP	CAL	17538
@NP	USA	17543
@NP	Statistica 10 -LRB- Statsoft , Tulsa	17553
@NP	Statistica 10	17553
@NP	Statsoft	17568
@NP	Tulsa	17578
@NP	USA	17589
@NP	statistical comparisons	17608
@NP	Baseline measurements of mean arterial pressure and heart rate	17633
@NP	Baseline measurements	17633
@NP	mean arterial pressure and heart rate	17658
@NP	mean arterial pressure	17658
@NP	heart rate	17685
@NP	one-way ANOVA	17713
@NP	treated and untreated animals	17735
@NP	post-hoc comparisons	17777
@NP	the Sidak test	17803
@NP	Mean arterial pressure and heart rate measurements after colorectal distension	17819
@NP	Mean arterial pressure	17819
@NP	heart rate measurements after colorectal distension	17846
@NP	heart rate measurements	17846
@NP	colorectal distension	17876
@NP	repeated-measures ANOVA	17915
@NP	the repeated measure	17945
@NP	time fromthe onset of colorectal distension	17970
@NP	time fromthe onset	17970
@NP	colorectal distension	17992
@NP	colorectal distention	18021
@NP	comparisons of Max	18044
@NP	comparisons	18044
@NP	Max	18059
@NP	arterial pressure , Max heart rate and T50	18068
@NP	arterial pressure	18068
@NP	Max heart rate	18087
@NP	T50	18106
@NP	arterial pressure between the two T4 transected groups	18115
@NP	arterial pressure	18115
@NP	the two T4 transected groups	18141
@NP	an unpaired Student 's t-test	18185
@NP	an unpaired Student 's	18185
@NP	Comparison of morphometric features	18215
@NP	Comparison	18215
@NP	morphometric features	18229
@NP	synaptic density	18255
@NP	the sympathetic preganglionic neurons rostral and caudal	18275
@NP	the injury in the OEC-transplanted group and fibroblast-transplanted groupwas	18335
@NP	the injury	18335
@NP	the OEC-transplanted group and fibroblast-transplanted groupwas	18349
@NP	the OEC-transplanted group	18349
@NP	fibroblast-transplanted groupwas	18380
@NP	a linear mixed model	18430
@NP	a restricted maximum likelihood algorithm	18457
@NP	fixed and random effects	18511
@NP	Kalincik	18537
@NP	et al. , 2010a ; Kalincik et al. , 2010b	18546
@NP	et al.	18546
@NP	2010a ; Kalincik et al.	18554
@NP	2010a	18554
@NP	Kalincik et al.	18561
@NP	Kalincik	18561
@NP	et al.	18570
@NP	2010b	18578
@NP	The effect	18586
@NP	treatment	18600
@NP	OEC vs. fibroblast	18611
@NP	OEC	18611
@NP	fibroblast	18619
@NP	position	18635
@NP	rostral vs. caudal to transection	18645
@NP	rostral	18645
@NP	caudal to transection	18657
@NP	caudal	18657
@NP	transection	18667
@NP	the subject effect	18706
@NP	The model	18748
@NP	an interaction between treatment and position	18773
@NP	an interaction	18773
@NP	treatment and position	18796
@NP	Constant correlation	18820
@NP	all pairs of measurements in the same animal	18857
@NP	all pairs	18857
@NP	measurements in the same animal	18870
@NP	measurements	18870
@NP	the same animal	18886
@NP	Results Fig. 1 .	18907
@NP	Results	18907
@NP	Fig. 1	18915
@NP	The recovery	18923
@NP	hypertension induced by colorectal distension	18941
@NP	hypertension	18941
@NP	colorectal distension	18965
@NP	duration indicated by ʻCRDʼ	18988
@NP	duration	18988
@NP	ʻCRDʼ	19010
@NP	the GFP-OECs-transplanted group	19031
@NP	Relative changes	19064
@NP	mean arterial pressure -LRB- A -RRB- and heart rate -LRB- B -RRB-	19084
@NP	mean arterial pressure	19084
@NP	A	19108
@NP	heart rate	19115
@NP	B	19127
@NP	colorectal distention	19137
@NP	Graphs	19160
@NP	averages of weeks 6 -- 8	19177
@NP	averages	19177
@NP	weeks 6 -- 8	19189
@NP	weeks	19189
@NP	6 -- 8	19195
@NP	no differences	19208
@NP	the heart rate response	19237
@NP	the mean arterial pressure response	19262
@NP	the mean	19262
@NP	arterial pressure response	19271
@NP	the groups -LRB- p = 0.013 , repeated measures ANOVA -RRB-	19329
@NP	the groups	19329
@NP	p = 0.013 , repeated measures ANOVA	19341
@NP	p	19341
@NP	0.013 , repeated measures ANOVA	19344
@NP	0.013	19344
@NP	measures	19360
@NP	ANOVA	19369
@NP	Recovery times T50 mean arterial pressures	19380
@NP	Recovery times	19380
@NP	T50	19395
@NP	arterial pressures	19404
@NP	GFPOECs - transplanted group for weeks 6 to 7	19453
@NP	GFPOECs	19453
@NP	transplanted group for weeks 6 to 7	19462
@NP	transplanted group	19462
@NP	weeks 6 to 7	19485
@NP	8 weeks following spinal cord injury	19509
@NP	8 weeks	19509
@NP	spinal cord injury	19527
@NP	All values	19547
@NP	the means	19568
@NP	p <	19591
@NP	p	19591
@NP	<	19593
@NP	0.05	19595
@NP	p <	19603
@NP	p	19603
@NP	<	19605
@NP	0.01	19607
@NP	Fig. 2 .	19614
@NP	Fig.	19614
@NP	2	19619
@NP	GFP-OECs	19622
@NP	9 weeks following spinal cord injury	19640
@NP	9 weeks	19640
@NP	spinal cord injury	19658
@NP	sympathetic preganglionic neurons	19699
@NP	Low magnification on longitudinal section	19734
@NP	Low magnification	19734
@NP	longitudinal section	19755
@NP	GFP-OECs clusters	19784
@NP	arrowheads	19803
@NP	their green fluorescence -LRB- A -RRB-	19839
@NP	their green fluorescence	19839
@NP	A	19865
@NP	A longitudinal section -LRB- similar anatomical reference as in A -RRB-	19869
@NP	A longitudinal section	19869
@NP	similar anatomical reference as in A	19893
@NP	similar anatomical reference	19893
@NP	A	19928
@NP	NADPH-diaphorase	19943
@NP	sympathetic preganglionic neurons	19966
@NP	the intermediolateral columns -LRB- arrows -RRB- -LRB- B -RRB-	20003
@NP	the intermediolateral columns -LRB- arrows -RRB-	20003
@NP	the intermediolateral columns	20003
@NP	arrows	20034
@NP	B	20043
@NP	OECs	20047
@NP	clusters or furrowed alongside the sympathetic preganglionic neurons columns	20087
@NP	clusters	20087
@NP	furrowed alongside the sympathetic preganglionic neurons columns	20099
@NP	the sympathetic preganglionic neurons	20118
@NP	Anti-Chat staining -LRB- red -RRB-	20165
@NP	Anti-Chat staining	20165
@NP	red	20185
@NP	a group of sympathetic preganglionic neurons -LRB- arrow -RRB-	20199
@NP	a group	20199
@NP	sympathetic preganglionic neurons -LRB- arrow -RRB-	20210
@NP	sympathetic preganglionic neurons	20210
@NP	arrow	20245
@NP	a column of GFP-OECs -LRB- arrowheads -RRB- -LRB- C -RRB-	20257
@NP	a column	20257
@NP	GFP-OECs -LRB- arrowheads -RRB- -LRB- C -RRB-	20269
@NP	GFP-OECs -LRB- arrowheads -RRB-	20269
@NP	GFP-OECs	20269
@NP	arrowheads	20279
@NP	C	20292
@NP	Confocal imaging	20296
@NP	the presence	20324
@NP	GFP-OECs	20340
@NP	arrowheads	20350
@NP	a group	20371
@NP	sympathetic preganglionic neurons -LRB- red , arrows -RRB- -LRB- D -RRB-	20382
@NP	sympathetic preganglionic neurons -LRB- red , arrows -RRB-	20382
@NP	sympathetic preganglionic neurons	20382
@NP	red , arrows	20417
@NP	red	20417
@NP	arrows	20422
@NP	D	20431
@NP	Fig. 3 .	20436
@NP	Fig.	20436
@NP	3	20441
@NP	The synaptic densities -LRB- green signal/red signal -RRB-	20444
@NP	The synaptic densities	20444
@NP	green signal/red signal	20468
@NP	sympathetic preganglionic neurons somata	20496
@NP	higher caudal	20542
@NP	the lesion in GFP-OECs-transplanted group	20559
@NP	the lesion	20559
@NP	GFP-OECs-transplanted group	20573
@NP	example	20605
@NP	a sympathetic preganglionic neuron -LRB- red -RRB-	20616
@NP	a sympathetic preganglionic neuron	20616
@NP	red	20652
@NP	multiple synaptic contacts	20662
@NP	arrows	20690
@NP	the injury site in a GFP-OECs-transplanted rat	20708
@NP	the injury site	20708
@NP	a GFP-OECs-transplanted rat	20727
@NP	B	20756
@NP	example	20759
@NP	a sympathetic preganglionic neuron	20770
@NP	multiple synaptic contacts -LRB- arrows -RRB-	20810
@NP	multiple synaptic contacts	20810
@NP	arrows	20838
@NP	the injury site in a fibroblasts-transplanted rat	20856
@NP	the injury site	20856
@NP	a fibroblasts-transplanted rat	20875
@NP	Significant effects	20907
@NP	both position and treatment were found -LRB- p ≤ 0.003 -RRB- -LRB- C -RRB-	20930
@NP	both position and treatment were found -LRB- p ≤ 0.003 -RRB-	20930
@NP	both position and treatment	20930
@NP	p	20970
@NP	≤ 0.003	20972
@NP	C	20982
@NP	The experiment	20987
@NP	nine transected rats	21013
@NP	GFP-OECs and nine transected rats	21052
@NP	fibroblasts	21104
@NP	One GFP-OECs transplanted animal died immediately after the T4 transection .	21117
@NP	One GFP-OECs	21117
@NP	transplanted animal	21130
@NP	the T4 transection	21173
@NP	3.1	21193
@NP	OEC transplantation	21198
@NP	autonomic dysreflexia Colorectal distensions	21226
@NP	consistent autonomic dysreflexic responses 6	21280
@NP	consistent autonomic dysreflexic responses	21280
@NP	6	21323
@NP	8 weeks after spinal cord transection	21325
@NP	8 weeks	21325
@NP	spinal cord transection	21339
@NP	transplantation of GFP-OECs or fibroblasts	21367
@NP	transplantation	21367
@NP	GFP-OECs or fibroblasts	21386
@NP	both groups	21414
@NP	colorectal distensions	21427
@NP	amarked increase	21457
@NP	mean arterial pressure	21477
@NP	80	21512
@NP	90 s	21515
@NP	the start of the inflation of the Foley catheter	21526
@NP	the start	21526
@NP	the inflation of the Foley catheter	21539
@NP	the inflation	21539
@NP	the Foley catheter	21556
@NP	baseline within 8 to 10 min -LRB- Fig. 1A -RRB-	21606
@NP	baseline	21606
@NP	8 to 10 min -LRB- Fig. 1A -RRB-	21622
@NP	8 to 10 min	21622
@NP	Fig. 1A	21634
@NP	This pressor response	21644
@NP	associatedwith a bradycardia -LRB- Fig. 1B -RRB-	21670
@NP	associatedwith a bradycardia	21670
@NP	associatedwith	21670
@NP	a bradycardia	21685
@NP	Fig. 1B	21700
@NP	There	22242
@NP	no effect of treatment for heart rate	22252
@NP	no effect	22252
@NP	treatment for heart rate	22265
@NP	treatment	22265
@NP	heart rate	22279
@NP	weeks	22293
@NP	6 , 7 or 8	22299
@NP	p N 0.23	22339
@NP	p N	22339
@NP	0.23	22343
@NP	The faster recovery from hypertension	22350
@NP	The faster recovery	22350
@NP	hypertension	22375
@NP	a comparison	22405
@NP	T50	22430
@NP	arterial pressure between the two groups -LRB- Fig. 1C -RRB-	22439
@NP	arterial pressure	22439
@NP	the two groups -LRB- Fig. 1C -RRB-	22465
@NP	the two groups	22465
@NP	Fig. 1C	22481
@NP	The average T50	22491
@NP	arterial pressure forweeks	22512
@NP	6 -- 8was	22539
@NP	26 % in the GFP-OEC-transplanted group	22557
@NP	26 %	22557
@NP	the GFP-OEC-transplanted group	22564
@NP	the fibroblast-transplanted group	22609
@NP	104 ± 7 s vs. 142 ± 10 s , p = 0.01 , Fig. 1C	22644
@NP	104 ±	22644
@NP	7 s vs. 142 ± 10 s , p = 0.01 , Fig. 1C	22650
@NP	7 s	22650
@NP	142 ± 10 s , p	22658
@NP	142 ± 10 s	22658
@NP	p	22670
@NP	0.01	22674
@NP	Fig. 1C	22680
@NP	The same analysis on weeks 6 to 8	22690
@NP	The same analysis	22690
@NP	weeks 6 to 8	22711
@NP	a significant difference	22746
@NP	weeks 6 and 7 -LRB- p < 0.047 -RRB-	22774
@NP	weeks 6 and 7	22774
@NP	p < 0.047	22789
@NP	p	22789
@NP	< 0.047	22791
@NP	<	22791
@NP	0.047	22793
@NP	8 week -LRB- p = 0.17 -RRB- following spinal cord injury -LRB- Fig. 1C -RRB-	22811
@NP	8 week -LRB- p = 0.17 -RRB-	22811
@NP	8 week	22811
@NP	p	22819
@NP	0.17	22822
@NP	spinal cord injury	22838
@NP	Fig. 1C	22858
@NP	3.2	22868
@NP	OECs	22873
@NP	nine weeks after transplantation Nine weeks	22891
@NP	nine weeks	22891
@NP	transplantation	22908
@NP	Nine weeks	22924
@NP	transplantation	22941
@NP	the spinal cord	22962
@NP	GFP-OECs	22979
@NP	caudal and rostral	23005
@NP	the injury site in all animals	23027
@NP	the injury site	23027
@NP	all animals	23046
@NP	Low magnification on longitudinal sections	23059
@NP	Low magnification	23059
@NP	longitudinal sections	23080
@NP	GFP-OECs clusters	23111
@NP	arrowheads	23130
@NP	their green fluorescence -LRB- Fig. 2A -RRB-	23166
@NP	their green fluorescence	23166
@NP	Fig. 2A	23192
@NP	a reference	23205
@NP	a longitudinal section stained for NADPH-diaphorase	23218
@NP	a longitudinal section	23218
@NP	NADPH-diaphorase	23253
@NP	sympathetic preganglionic neurons	23276
@NP	the intermediolateral columns -LRB- Fig. 2B -RRB-	23313
@NP	the intermediolateral columns	23313
@NP	Fig. 2B	23344
@NP	all animals	23357
@NP	OECs	23370
@NP	clusters or furrowed alongside the sympathetic preganglionic neuron columns	23409
@NP	clusters	23409
@NP	furrowed alongside the sympathetic preganglionic neuron columns	23421
@NP	the sympathetic preganglionic neuron	23440
@NP	Anti-choline acetyltransferase staining -LRB- red -RRB-	23486
@NP	Anti-choline acetyltransferase staining	23486
@NP	red	23527
@NP	a group	23538
@NP	sympathetic preganglionic neurons near a column of GFP-OECs -LRB- Fig. 2C -RRB-	23549
@NP	sympathetic preganglionic neurons	23549
@NP	a column of GFP-OECs -LRB- Fig. 2C -RRB-	23588
@NP	a column	23588
@NP	GFP-OECs -LRB- Fig. 2C -RRB-	23600
@NP	GFP-OECs	23600
@NP	Fig. 2C	23610
@NP	Confocal imaging	23620
@NP	the presence	23645
@NP	GFP-OECs	23661
@NP	the close vicinity of sympathetic preganglionic neurons -LRB- Fig. 2D -RRB-	23673
@NP	the close vicinity	23673
@NP	sympathetic preganglionic neurons -LRB- Fig. 2D -RRB-	23695
@NP	sympathetic preganglionic neurons	23695
@NP	Fig. 2D	23730
@NP	3.3	23740
@NP	OEC transplantation altered morphology of sympathetic preganglionic neurons	23745
@NP	OEC transplantation	23745
@NP	altered morphology of sympathetic preganglionic neurons	23765
@NP	altered morphology	23765
@NP	sympathetic preganglionic neurons	23787
@NP	There	23821
@NP	differences	23832
@NP	animals	23852
@NP	OEC or fibroblasts	23878
@NP	the morphology of preganglionic sympathetic neurons	23900
@NP	the morphology	23900
@NP	preganglionic sympathetic neurons	23918
@NP	Morphometric features	23953
@NP	NADPH-diaphorase-immunoreactive sympathetic preganglionic neurons	23978
@NP	the intermediolateral columns	24047
@NP	the spinal cord transection site	24099
@NP	9 weeks	24146
@NP	spinal cord injury	24160
@NP	completion of functional assessments	24185
@NP	completion	24185
@NP	functional assessments	24199
@NP	Soma size , overall dendrite length and number of primary dendrites	24223
@NP	Soma size	24223
@NP	overall dendrite length	24234
@NP	number of primary dendrites	24262
@NP	number	24262
@NP	primary dendrites	24272
@NP	the transplanted groups	24312
@NP	a 3 × 2 -LRB- group × position -RRB- linear mixed model analysis	24342
@NP	3 ×	24344
@NP	2	24348
@NP	group × position	24351
@NP	group	24351
@NP	× position	24357
@NP	The mean soma size	24398
@NP	significantly smaller caudal vs. rostral	24421
@NP	the injury -LRB- p = 0.03 -RRB-	24465
@NP	the injury	24465
@NP	p	24477
@NP	0.03	24481
@NP	A trend towards smaller soma size	24488
@NP	A trend	24488
@NP	smaller soma size	24504
@NP	the OEC-treated animals	24534
@NP	the fibroblast-treated animals -LRB- p = 0.07 -RRB-	24570
@NP	the fibroblast-treated animals	24570
@NP	p	24602
@NP	0.07	24606
@NP	Mean sympathetic preganglionic neuron dendritic length	24613
@NP	Mean sympathetic preganglionic neuron	24613
@NP	dendritic length	24651
@NP	the caudal vs. rostral position -LRB- p = 0.0001 -RRB-	24683
@NP	the caudal	24683
@NP	rostral position -LRB- p = 0.0001 -RRB-	24698
@NP	rostral position	24698
@NP	p	24716
@NP	0.0001	24720
@NP	The overall number of primary dendrites	24729
@NP	The overall number	24729
@NP	primary dendrites	24751
@NP	the caudal position -LRB- p = 0.02 -RRB-	24784
@NP	the caudal position	24784
@NP	p	24805
@NP	0.02	24809
@NP	the OECtreated animals -LRB- p = 0.005 -RRB-	24822
@NP	the OECtreated animals	24822
@NP	p	24846
@NP	0.005	24848
@NP	No statistically significant interactions between position and treatment	24856
@NP	No statistically significant interactions	24856
@NP	position and treatment	24906
@NP	3.4	24944
@NP	OEC transplantation	24949
@NP	synaptic density	24977
@NP	the somata of sympathetic preganglionic neurons	24997
@NP	the somata	24997
@NP	sympathetic preganglionic neurons	25011
@NP	Synaptic densities	25045
@NP	the overlay of the punctate synaptophysin immunoreactivitywith	25083
@NP	the overlay	25083
@NP	the punctate synaptophysin immunoreactivitywith	25098
@NP	the choline acetyltransferase immunoreactivity	25146
@NP	the preganglionic sympathetic neurons -LRB- Fig. 3A , B -RRB-	25196
@NP	the preganglionic sympathetic neurons	25196
@NP	Fig. 3A , B	25235
@NP	Fig. 3A	25235
@NP	B	25244
@NP	the GFP-OECs transplanted group , caudal to the injury site	25251
@NP	the GFP-OECs	25251
@NP	group , caudal to the injury site	25277
@NP	group	25277
@NP	caudal to the injury site	25284
@NP	caudal	25284
@NP	the injury site	25294
@NP	numerous sympathetic preganglionic neurons	25311
@NP	large numbers of synaptophysin-positive puncta	25359
@NP	large numbers	25359
@NP	synaptophysin-positive puncta	25376
@NP	Fig. 3A	25421
@NP	fibroblasts-transplanted rats	25442
@NP	sympathetic preganglionic neurons	25473
@NP	less synaptophysin staining -LRB- Fig. 3B -RRB-	25514
@NP	less synaptophysin staining	25514
@NP	Fig. 3B	25543
@NP	The sympathetic preganglionic neuron synaptic density	25553
@NP	the sympathetic preganglionic neurons	25621
@NP	caudal to the injury site -LRB- p ≤ 0.003 -RRB-	25671
@NP	caudal to the injury site	25671
@NP	the injury	25681
@NP	p ≤ 0.003	25698
@NP	p	25698
@NP	≤ 0.003	25700
@NP	Comparison between OEC-transplanted animals and fibroblasttransplanted animals	25710
@NP	Comparison	25710
@NP	OEC-transplanted animals and fibroblasttransplanted animals	25729
@NP	OEC-transplanted animals	25729
@NP	fibroblasttransplanted animals	25758
@NP	an increased synaptic density	25798
@NP	OECstransplanted animals	25831
@NP	the injury site -LRB- p = 0.05 -RRB- -LRB- Fig. 3C -RRB-	25866
@NP	the injury site -LRB- p = 0.05 -RRB-	25866
@NP	the injury site	25866
@NP	p	25883
@NP	0.05	25887
@NP	Fig. 3C	25894
@NP	No statistically significant interaction between position and treatment	25904
@NP	No statistically significant interaction	25904
@NP	position and treatment	25953
@NP	p = 0.36	25990
@NP	p	25990
@NP	= 0.36	25991
@NP	Discussion This study	26004
@NP	Discussion	26004
@NP	This study	26015
@NP	a cell	26039
@NP	type-specific therapeutic effect	26046
@NP	autonomic dysreflexia of transplantation of OECs	26082
@NP	autonomic dysreflexia	26082
@NP	transplantation of OECs	26107
@NP	transplantation	26107
@NP	OECs	26126
@NP	fibroblasts	26143
@NP	This effect of OECs	26156
@NP	This effect	26156
@NP	OECs	26171
@NP	our previous observations	26185
@NP	a non-cell control group -LRB- Kalincik et al. , 2010a -RRB-	26216
@NP	a non-cell control group	26216
@NP	Kalincik	26242
@NP	et al. , 2010a	26251
@NP	et al.	26251
@NP	2010a	26259
@NP	this study	26281
@NP	survival of OECs	26303
@NP	survival	26303
@NP	OECs	26315
@NP	transplantation	26336
@NP	the spinal cord tissue	26357
@NP	the lesion site -LRB- at least 9 weeks survival -RRB-	26392
@NP	the lesion site	26392
@NP	9 weeks	26418
@NP	survival	26426
@NP	the lesion itself -LRB- 3weeks ; Kalincik et al. , 2010a -RRB-	26453
@NP	the lesion itself	26453
@NP	the lesion	26453
@NP	3weeks ; Kalincik et al. , 2010a	26472
@NP	3weeks	26472
@NP	Kalincik et al. , 2010a	26480
@NP	Kalincik	26480
@NP	et al. , 2010a	26489
@NP	et al.	26489
@NP	2010a	26497
@NP	The histological analysis	26505
@NP	a mechanism	26540
@NP	reorganization of the synaptic inputs to sympathetic preganglionic neurons	26562
@NP	reorganization	26562
@NP	the synaptic inputs to sympathetic preganglionic neurons	26580
@NP	the synaptic inputs	26580
@NP	sympathetic preganglionic neurons	26603
@NP	their primary dendrites	26641
@NP	the site of spinal cord injury	26675
@NP	the site	26675
@NP	spinal cord injury	26687
@NP	4.1	26707
@NP	mean arterial pressure and heart rate After T4 spinal cord transection injury	26720
@NP	mean arterial pressure and heart rate	26720
@NP	mean arterial pressure	26720
@NP	heart rate	26747
@NP	T4 spinal cord transection injury	26764
@NP	T4	26764
@NP	spinal cord transection injury	26767
@NP	there	26798
@NP	a fall	26807
@NP	mean arterial pressure	26825
@NP	a rise	26863
@NP	heart rate	26881
@NP	both cardiovascular parameters	26898
@NP	their new baseline values	26949
@NP	3	26979
@NP	8 weeks	26981
@NP	injury	26995
@NP	Kalincik et al. , 2010a ; Krassioukov et al. , 1995 ; Laird et al. , 2006	27003
@NP	Kalincik	27003
@NP	et al. , 2010a ; Krassioukov et al. , 1995 ; Laird et al. , 2006	27012
@NP	et al. , 2010a	27012
@NP	et al.	27012
@NP	2010a	27020
@NP	Krassioukov et al. , 1995	27027
@NP	Krassioukov	27027
@NP	et al. , 1995	27039
@NP	et al.	27039
@NP	1995	27047
@NP	Laird et al. , 2006	27053
@NP	Laird	27053
@NP	et al. , 2006	27059
@NP	et al.	27059
@NP	2006	27067
@NP	Transplantation of OECs	27074
@NP	Transplantation	27074
@NP	OECs	27093
@NP	these baseline	27113
@NP	measurements in this study -LRB- data not shown -RRB- or previously	27128
@NP	measurements in this study -LRB- data not shown -RRB-	27128
@NP	measurements	27128
@NP	this study -LRB- data not shown -RRB-	27144
@NP	this study	27144
@NP	data not shown	27156
@NP	data	27156
@NP	Kalincik et al. , 2010a	27187
@NP	Kalincik	27187
@NP	et al.	27196
@NP	2010a	27204
@NP	4.2	27212
@NP	Olfactory ensheathing cell	27217
@NP	autonomic dysreflexia OEC transplantation	27248
@NP	the lesion site	27295
@NP	Kalincik	27312
@NP	et al. , 2010a	27321
@NP	et al.	27321
@NP	2010a	27329
@NP	the spinal cord parenchyma	27339
@NP	present study	27367
@NP	a faster recovery of the mean arterial pressure response	27391
@NP	a faster recovery	27391
@NP	the mean arterial pressure response	27412
@NP	colorectal distensions compared to the control groups	27451
@NP	colorectal distensions	27451
@NP	the control groups	27486
@NP	OEC transplantation into the spinal cord parenchyma	27506
@NP	OEC transplantation	27506
@NP	the spinal cord parenchyma	27531
@NP	a 26 % reduction	27570
@NP	the period	27589
@NP	increased arterial pressure	27603
@NP	the T50	27645
@NP	arterial pressure response	27658
@NP	6	27694
@NP	8 weeks	27696
@NP	spinal cord injury	27710
@NP	the previously reported 22 % reduction measured 3	27741
@NP	the previously reported 22 % reduction	27741
@NP	3	27788
@NP	8 weeks after spinal cord injury and OEC transplantation into the lesion site	27790
@NP	8 weeks	27790
@NP	spinal cord injury and OEC transplantation into the lesion site	27804
@NP	spinal cord injury and OEC transplantation	27804
@NP	the lesion site	27852
@NP	Kalincik	27869
@NP	et al. , 2010a	27878
@NP	et al.	27878
@NP	2010a	27886
@NP	analysis on weeks 6 to 8	27903
@NP	analysis	27903
@NP	weeks 6 to 8	27915
@NP	the faster recovery from hypertension	27955
@NP	the faster recovery	27955
@NP	hypertension	27980
@NP	OECs transplanted animals faded at 8 weeks	28005
@NP	OECs	28005
@NP	transplanted animals	28010
@NP	8 weeks	28040
@NP	The longer survival of OECs in the present study	28049
@NP	The longer survival	28049
@NP	OECs in the present study	28072
@NP	OECs	28072
@NP	the present study	28080
@NP	the reduction of autonomic dysreflexia	28114
@NP	the reduction	28114
@NP	autonomic dysreflexia	28131
@NP	the therapeutic effect of OECs	28171
@NP	the therapeutic effect	28171
@NP	OECs	28197
@NP	their continuing survival	28240
@NP	Further studies	28267
@NP	the mechanism	28311
@NP	the transient effect	28336
@NP	the therapeutic beneficial effect	28377
@NP	4.3	28412
@NP	Olfactory ensheathing cell	28417
@NP	sympathetic preganglionic neuron morphology	28448
@NP	The number of primary dendrites	28492
@NP	The number	28492
@NP	primary dendrites	28506
@NP	the spinal cord injury	28534
@NP	OEC transplanted animals	28586
@NP	a cell specific action	28630
@NP	OECs	28671
@NP	the sympathetic preganglionic neuronmorphology	28687
@NP	our group -LRB- Kalincik et al. , 2010b -RRB-	28765
@NP	our group	28765
@NP	Kalincik	28776
@NP	et al. , 2010b	28785
@NP	et al.	28785
@NP	2010b	28793
@NP	This	28801
@NP	the primary dendrites	28820
@NP	the spinal cord injurymight	28852
@NP	a key role	28885
@NP	the reduction of autonomic dysreflexia seen in OECs	28899
@NP	the reduction	28899
@NP	autonomic dysreflexia seen in OECs	28916
@NP	autonomic dysreflexia	28916
@NP	OECs	28946
@NP	transplanted animals	28951
@NP	It	28973
@NP	we	29008
@NP	the same pattern	29020
@NP	the effect of treatment	29041
@NP	the effect	29041
@NP	treatment	29055
@NP	soma size -LRB- Kalincik et al. , 2010b -RRB-	29068
@NP	soma size	29068
@NP	Kalincik	29079
@NP	et al. , 2010b	29088
@NP	et al.	29088
@NP	2010b	29096
@NP	it	29113
@NP	a statistically significant level	29130
@NP	the other hand	29168
@NP	the relative increase	29184
@NP	dendritic length rostral to the lesion -LRB- Kalincik et al. , 2010b -RRB-	29209
@NP	dendritic length rostral	29209
@NP	the lesion -LRB- Kalincik et al. , 2010b -RRB-	29237
@NP	the lesion	29237
@NP	Kalincik	29249
@NP	et al. , 2010b	29258
@NP	et al.	29258
@NP	2010b	29266
@NP	the present study	29294
@NP	The reasons underlying those differences	29313
@NP	The reasons	29313
@NP	those differences	29336
@NP	a different transplant site environment plus a longer survival time of OECs	29393
@NP	a different transplant site environment	29393
@NP	a longer survival time of OECs	29438
@NP	a longer survival time	29438
@NP	OECs	29464
@NP	Another hypothetic reason	29470
@NP	fibroblasts	29516
@NP	Fibroblasts	29529
@NP	a control cell	29566
@NP	various candidate cells studied for transplant mediated repair	29592
@NP	various candidate cells	29592
@NP	transplant	29628
@NP	repair	29648
@NP	The use of this cell type for this purpose	29656
@NP	The use	29656
@NP	this cell type for this purpose	29667
@NP	this cell type	29667
@NP	this purpose	29686
@NP	the assumption	29711
@NP	they	29731
@NP	a neutral cell type	29740
@NP	little or no repair	29765
@NP	properties -LRB- Keyvan-Fouladi et al. , 2005 ; Pearse et al. , 2007 -RRB-	29795
@NP	properties	29795
@NP	Keyvan-Fouladi	29807
@NP	et al. , 2005 ; Pearse et al. , 2007	29822
@NP	et al.	29822
@NP	2005 ; Pearse et al.	29830
@NP	2005	29830
@NP	Pearse et al.	29836
@NP	Pearse	29836
@NP	et al.	29843
@NP	2007	29851
@NP	fibroblasts	29867
@NP	nerve growth factor -LRB- Olgart et al. , 2001 -RRB-	29900
@NP	nerve growth factor	29900
@NP	Olgart	29921
@NP	et al. , 2001	29928
@NP	et al.	29928
@NP	2001	29936
@NP	it	29946
@NP	fibroblast-like cells	29979
@NP	significant regeneration of axons after transplantation	30013
@NP	significant regeneration	30013
@NP	axons after transplantation	30041
@NP	axons	30041
@NP	transplantation	30053
@NP	dorsal column lesions -LRB- Toft et al. , 2013 -RRB-	30074
@NP	dorsal column lesions	30074
@NP	Toft	30097
@NP	et al. , 2013	30102
@NP	et al.	30102
@NP	2013	30110
@NP	improved locomotor scores -LRB- Suh et al. , 2011 -RRB-	30119
@NP	improved locomotor scores	30119
@NP	Suh	30146
@NP	et al. , 2011	30150
@NP	et al.	30150
@NP	2011	30158
@NP	Fibroblasts	30165
@NP	astroglial scar formation and increase immune-cell infiltration	30188
@NP	concomitant secondary tissue damage -LRB- Khankan et al. , 2016 -RRB-	30256
@NP	concomitant secondary tissue damage	30256
@NP	Khankan	30293
@NP	et al. , 2016	30301
@NP	et al.	30301
@NP	2016	30309
@NP	No studies	30316
@NP	the impacts of fibroblasts	30345
@NP	the impacts	30345
@NP	fibroblasts	30360
@NP	autonomic dysreflexia	30381
@NP	the morphology of sympathetic preganglionic neurons	30410
@NP	the morphology	30410
@NP	sympathetic preganglionic neurons	30428
@NP	we	30473
@NP	a potential effect	30492
@NP	fibroblasts on sympathetic preganglionic neuronswhich	30514
@NP	fibroblasts	30514
@NP	sympathetic preganglionic neuronswhich	30529
@NP	our differences	30582
@NP	our previous study -LRB- Kalincik et al. , 2010a -RRB-	30610
@NP	our previous study	30610
@NP	Kalincik	30630
@NP	et al. , 2010a	30639
@NP	et al.	30639
@NP	2010a	30647
@NP	4.4	30655
@NP	Olfactory ensheathing cell and synaptic density	30660
@NP	Olfactory ensheathing cell	30660
@NP	synaptic density	30691
@NP	The anatomy	30708
@NP	synaptic circuits	30723
@NP	sympathetic preganglionic neuron activity	30753
@NP	excitatory or inhibitory synaptic connections	30811
@NP	the brain stem	30870
@NP	spinal interneurons	30894
@NP	Llewellyn-Smith	30915
@NP	2009	30932
@NP	OEC transplantation	30939
@NP	the density of synaptic contacts	30969
@NP	the density	30969
@NP	synaptic contacts	30984
@NP	spinal cord injury	31012
@NP	fibroblast transplantation	31043
@NP	the improvement in autonomic dysreflexia	31077
@NP	the improvement	31077
@NP	autonomic dysreflexia	31096
@NP	OEC transplantation	31124
@NP	it	31144
@NP	this increase in synaptic density on caudal sympathetic ganglionic neurons	31164
@NP	this increase	31164
@NP	synaptic density on caudal sympathetic ganglionic neurons	31181
@NP	synaptic density	31181
@NP	caudal sympathetic ganglionic neurons	31201
@NP	OECinduced neuroplasticity	31248
@NP	our best knowledge	31279
@NP	it	31299
@NP	the first report	31305
@NP	OECs	31327
@NP	a modulatory effect	31337
@NP	synaptic density sympathetic preganglionic neurons in vivo	31360
@NP	synaptic density sympathetic preganglionic neurons	31360
@NP	vivo	31414
@NP	we	31423
@NP	transplanted OECs	31453
@NP	autonomic dysreflexia	31482
@NP	changes	31519
@NP	sympathetic preganglionic neurons morphology	31530
@NP	synaptic density that indicate therapeutic neuroplasticity	31579
@NP	synaptic density	31579
@NP	therapeutic neuroplasticity	31610
@NP	These benefits	31639
@NP	the OECs	31669
@NP	the time of the spinal cord injury	31699
@NP	the time	31699
@NP	the spinal cord injury	31711
@NP	the first human clinical trials of transplanted autologous OECs	31744
@NP	the first human clinical trials	31744
@NP	transplanted autologous OECs	31779
@NP	patients	31830
@NP	chronicmid-thoracic spinal cord injuries	31844
@NP	Feron	31886
@NP	et al. , 2005 ; Tabakow et al. , 2014	31892
@NP	et al.	31892
@NP	2005 ; Tabakow et al.	31900
@NP	2005	31900
@NP	Tabakow et al.	31906
@NP	Tabakow	31906
@NP	et al.	31914
@NP	2014	31922
@NP	It	31929
@NP	patients with chronic high-thoracic injuries and autonomic dysreflexia	31971
@NP	patients	31971
@NP	chronic high-thoracic injuries and autonomic dysreflexia	31985
@NP	chronic high-thoracic injuries	31985
@NP	autonomic dysreflexia	32020
@NP	OEC transplantation	32060
@NP	chronic injuries	32084
@NP	the more likely clinical application	32105
@VP	injured rats a b s t r a c t Autonomic dysreflexia	109
@VP	s t r a c t Autonomic dysreflexia	128
@VP	is a common complication after high level spinal cord injury	162
@VP	can be life-threatening	227
@VP	be life-threatening	231
@VP	transected at the fourth thoracic spinal cord level	367
@VP	reduced autonomic dysreflexia up to 8 weeks after spinal cord injury	419
@VP	surviving no longer than 3 weeks	623
@VP	reduce the duration of autonomic dysreflexia	1065
@VP	modulate sympathetic preganglionic neuronmorphology	1114
@VP	requires synaptic changes	1337
@VP	comparing their effects with a control group transplanted with fibroblasts	1453
@VP	transplanted with fibroblasts	1498
@VP	transplanted with OECs	1537
@VP	survived for at least 8 weeks	1731
@VP	was reduced	1867
@VP	reduced	1871
@VP	increased	1918
@VP	1	2212
@VP	is	2464
@VP	is characterized by a sudden	2495
@VP	characterized by a sudden	2498
@VP	leading to extremely high arterial blood pressure	2617
@VP	reviewed in -LRB- Wan et al. , 2014 -RRB-	2815
@VP	decreasing cavity formation	3161
@VP	demyelinated axons	3255
@VP	reduced the duration of autonomic dysreflexia	3668
@VP	changed the morphology of spinal cord	3718
@VP	persisted for 9 weeks after OEC transplantation	4609
@VP	were only temporary -LRB- Kalincik et al. , 2010b -RRB-	4705
@VP	transplanted into the lesion site immediately after the spinal cord transection	4786
@VP	initiated long-term functional as well as morphological changes	4964
@VP	reduce the duration of autonomic dysreflexia	5444
@VP	modulate sympathetic preganglionic neuron morphology	5493
@VP	requires synaptic changes	6270
@VP	observed	6345
@VP	not induced by fibroblasts -LRB- control group -RRB-	6868
@VP	generalized response to cell transplantation	6916
@VP	2	6963
@VP	maintained on a 12/12 h light/dark cycle	7244
@VP	were used for harvesting and culture of OECs and fibroblasts	7715
@VP	used for harvesting and culture of OECs and fibroblasts	7720
@VP	were deeply anaesthetized with pentobarbitone -LRB- 0.5 ml intraperitoneally	7788
@VP	anaesthetized with pentobarbitone -LRB- 0.5 ml intraperitoneally	7800
@VP	and killed by decapitation	7906
@VP	killed by decapitation	7910
@VP	described	8017
@VP	described	8137
@VP	described previously	8406
@VP	described previously	8520
@VP	described previously	8970
@VP	pulled glass tip -LRB- with inner diameter of 80 -- 100 μm -RRB-	9230
@VP	was left in situ for 1 -- 2 min to prevent reflux	9549
@VP	left in situ for 1 -- 2 min to prevent reflux	9553
@VP	to prevent reflux	9578
@VP	prevent reflux	9581
@VP	received fibroblasts at similar concentrations	9621
@VP	confirmed with a scalpel blade and observation under the dissecting microscope	9802
@VP	was present between the rostral and caudal ends of the cord	9935
@VP	was inserted to fill the gap and reduce bleeding	10101
@VP	inserted to fill the gap and reduce bleeding	10105
@VP	to fill the gap and reduce bleeding	10114
@VP	fill the gap and reduce bleeding	10117
@VP	fill the gap	10117
@VP	reduce bleeding	10134
@VP	was also placed on the dorsal surface of the cord	10194
@VP	placed on the dorsal surface of the cord	10203
@VP	were sutured in layers	10275
@VP	sutured in layers	10280
@VP	noted by cloudiness of expressed urine	10614
@VP	was administered 2 -- 3 times daily until the rats were able to drink normally	10909
@VP	administered 2 -- 3 times daily until the rats were able to drink normally	10913
@VP	were able to drink normally	10957
@VP	to drink normally	10967
@VP	drink normally	10970
@VP	developed a micturition reflex -LRB- ~ 2 weeks -RRB-	11070
@VP	was maintained at 27 -- 28 °C for the first 1	11134
@VP	maintained at 27 -- 28 °C for the first 1	11138
@VP	was measured regularly until normal temperature was maintained	11210
@VP	measured regularly until normal temperature was maintained	11214
@VP	was maintained	11258
@VP	maintained	11262
@VP	was maintained at 26 °C until the end of the experiment	11295
@VP	maintained at 26 °C until the end of the experiment	11299
@VP	described previously	11629
@VP	carried out at 6 , 7 and 8 weeks after the spinal cord injury	11743
@VP	performed as described previously	11808
@VP	described previously	11821
@VP	was calculated from three distensions made during the recording period	11889
@VP	calculated from three distensions made during the recording period	11893
@VP	made during the recording period	11927
@VP	was recorded	12075
@VP	recorded	12079
@VP	were calculated	12158
@VP	calculated	12163
@VP	were turned on	12343
@VP	turned on	12348
@VP	were recorded over a 20 min period whilst rats were at rest in their home cage	12560
@VP	recorded over a 20 min period whilst rats were at rest in their home cage	12565
@VP	were at rest in their home cage	12607
@VP	was then calculated over the entire 20 min period	12703
@VP	calculated over the entire 20 min period	12712
@VP	resting cardiovascular parameters	12770
@VP	mean arterial pressure and heart rate	12805
@VP	were recorded in a group of 6 adult male AAWrats without spinal cord injury	12844
@VP	recorded in a group of 6 adult male AAWrats without spinal cord injury	12849
@VP	were made from the experimental animals with the same settings	12964
@VP	made from the experimental animals with the same settings	12969
@VP	were removed and the femoral artery ligated	13806
@VP	ligated	13842
@VP	extending 1 cm above and 1 cm below the injection/injury site	14154
@VP	fixed in the same fixative overnight	14237
@VP	then transferred into a solution of 30 % sucrose in 0.1 Mphosphate buffer	14278
@VP	sectioned horizontally at 35 μm with a cryostat	14373
@VP	collected on gelatin-coated slides in series of four , air-dried	14425
@VP	stored at − 22 °C	14493
@VP	washed in phosphate-buffered saline	15207
@VP	were included in each run	15419
@VP	included in each run	15424
@VP	were held constant for all images	15685
@VP	held constant for all images	15690
@VP	to identify the sympathetic preganglionic neurons	15809
@VP	identify the sympathetic preganglionic neurons	15812
@VP	, to identify synaptic boutons	15886
@VP	to identify synaptic boutons	15888
@VP	identify synaptic boutons	15891
@VP	, to identify nuclei	15932
@VP	to identify nuclei	15934
@VP	identify nuclei	15937
@VP	passed through the central plane of the nucleus -LRB- blue channel -RRB-	16094
@VP	to ensure that the red cell cytoplasmcompletely surrounded the blue cell nucleus	16158
@VP	ensure that the red cell cytoplasmcompletely surrounded the blue cell nucleus	16161
@VP	surrounded the blue cell nucleus	16206
@VP	followed by thresholding to produce a binary image	16308
@VP	thresholding to produce a binary image	16320
@VP	to produce a binary image	16333
@VP	produce a binary image	16336
@VP	did not touch the border of the cell image	16396
@VP	touch the border of the cell image	16404
@VP	were filled to create an initial cell mask	16439
@VP	filled to create an initial cell mask	16444
@VP	to create an initial cell mask	16451
@VP	create an initial cell mask	16454
@VP	to create a larger second cell mask	16538
@VP	create a larger second cell mask	16541
@VP	defining a 1.54 μm	16617
@VP	were counted	16785
@VP	counted	16790
@VP	were analyzed as described by -LRB- Kalincik et al. , 2010a -RRB-	16951
@VP	analyzed as described by -LRB- Kalincik et al. , 2010a -RRB-	16956
@VP	described by -LRB- Kalincik et al. , 2010a -RRB-	16968
@VP	selected	17229
@VP	selected for analysis	17271
@VP	were measured using ImageJ software	17387
@VP	measured using ImageJ software	17392
@VP	using ImageJ software	17401
@VP	were used for statistical comparisons	17594
@VP	used for statistical comparisons	17599
@VP	followed by post-hoc comparisons with the Sidak test	17765
@VP	was time fromthe onset of colorectal distension	17966
@VP	were made with an unpaired Student 's t-test	18170
@VP	made with an unpaired Student 's t-test	18175
@VP	were considered fixed	18680
@VP	considered fixed	18685
@VP	fixed	18696
@VP	was considered random	18725
@VP	considered random	18729
@VP	evaluated an interaction between treatment and position	18763
@VP	was assumed for all pairs of measurements in the same animal	18841
@VP	assumed for all pairs of measurements in the same animal	18845
@VP	3	18904
@VP	induced by colorectal distension	18954
@VP	indicated by ʻCRDʼ	18997
@VP	was faster in the GFP-OECs-transplanted group	19017
@VP	represent averages of weeks 6 -- 8	19167
@VP	were found in the heart rate response	19223
@VP	found in the heart rate response	19228
@VP	differed between the groups -LRB- p = 0.013 , repeated measures ANOVA -RRB-	19312
@VP	= 0.013 , repeated measures ANOVA	19342
@VP	repeated measures ANOVA	19351
@VP	mean arterial pressures	19399
@VP	represent the means ± s.e.mean	19558
@VP	± s.e.mean	19578
@VP	survived 9 weeks following spinal cord injury	19631
@VP	were located near sympathetic preganglionic neurons	19681
@VP	easily distinguished by their green fluorescence -LRB- A -RRB-	19815
@VP	stained for NADPH-diaphorase	19931
@VP	were higher caudal to the lesion in GFP-OECs-transplanted group	20537
@VP	caudal to the injury site in a GFP-OECs-transplanted rat	20698
@VP	caudal to the injury site in a fibroblasts-transplanted rat	20846
@VP	were found -LRB- p ≤ 0.003 -RRB-	20958
@VP	found -LRB- p ≤ 0.003 -RRB-	20963
@VP	transplanted with fibroblasts	21086
@VP	died immediately after the T4 transection	21150
@VP	gradually returned to baseline within 8 to 10 min -LRB- Fig. 1A -RRB-	21584
@VP	was associatedwith a bradycardia -LRB- Fig. 1B -RRB-	21666
@VP	considered individually -LRB- p N 0.23 -RRB-	22314
@VP	averaged T50 mean arterial pressure between the two groups -LRB- Fig. 1C -RRB-	22421
@VP	mean arterial pressure between the two groups -LRB- Fig. 1C -RRB-	22434
@VP	were distributed caudal and rostral to the injury site in all animals	22988
@VP	distributed caudal and rostral to the injury site in all animals	22993
@VP	easily distinguished by their green fluorescence -LRB- Fig. 2A -RRB-	23142
@VP	stained for NADPH-diaphorase	23241
@VP	using a 3 × 2 -LRB- group × position -RRB- linear mixed model analysis	24336
@VP	was significantly smaller caudal vs. rostral to the injury -LRB- p = 0.03 -RRB-	24417
@VP	was shorter in the caudal vs. rostral position -LRB- p = 0.0001 -RRB-	24668
@VP	were observed	24929
@VP	observed	24934
@VP	reduced synaptic density on the somata of sympathetic preganglionic neurons	24969
@VP	transplanted group , caudal to the injury site	25264
@VP	observed -LRB- Fig. 3A -RRB-	25411
@VP	showed less synaptophysin staining -LRB- Fig. 3B -RRB-	25507
@VP	was observed -LRB- p = 0.36 -RRB-	25976
@VP	observed -LRB- p = 0.36 -RRB-	25980
@VP	4	26001
@VP	caudal to the site of spinal cord injury	26665
@VP	resting heart rate	26873
@VP	not shown	27161
@VP	measured 3	27779
@VP	observed in OECs transplanted animals faded at 8 weeks	27993
@VP	faded at 8 weeks	28031
@VP	did not improve the reduction of autonomic dysreflexia	28098
@VP	improve the reduction of autonomic dysreflexia	28106
@VP	may be transient and not dependent on their continuing survival	28202
@VP	be transient and not dependent on their continuing survival	28206
@VP	to improve the therapeutic beneficial effect	28366
@VP	improve the therapeutic beneficial effect	28369
@VP	caudal to the spinal cord injury	28524
@VP	demonstrates a cell specific action	28617
@VP	shown by our group -LRB- Kalincik et al. , 2010b -RRB-	28756
@VP	play a key role in the reduction of autonomic dysreflexia seen in OECs	28880
@VP	seen in OECs	28938
@VP	did not reach a statistically significant level	29116
@VP	reach a statistically significant level	29124
@VP	was not observed in the present study	29274
@VP	observed in the present study	29282
@VP	underlying those differences	29325
@VP	remain unknown	29354
@VP	could be related to fibroblasts	29496
@VP	be related to fibroblasts	29502
@VP	related to fibroblasts	29505
@VP	studied for transplant mediated repair	29616
@VP	mediated repair	29639
@VP	are known to secrete nerve growth factor -LRB- Olgart et al. , 2001 -RRB-	29879
@VP	known to secrete nerve growth factor -LRB- Olgart et al. , 2001 -RRB-	29883
@VP	to secrete nerve growth factor -LRB- Olgart et al. , 2001 -RRB-	29889
@VP	secrete nerve growth factor -LRB- Olgart et al. , 2001 -RRB-	29892
@VP	arising from the brain stem and from spinal interneurons	30857
@VP	caudal to spinal cord injury compared to fibroblast transplantation	31002
@VP	reflects OECinduced neuroplasticity	31239
@VP	show here , and previously	31426
@VP	can reduce autonomic dysreflexia	31471
@VP	reduce autonomic dysreflexia	31475
@VP	indicate therapeutic neuroplasticity	31601
@VP	were seen when the OECs were transplanted at the time of the spinal cord injury	31654
@VP	seen when the OECs were transplanted at the time of the spinal cord injury	31659
@VP	were transplanted at the time of the spinal cord injury	31678
@VP	transplanted at the time of the spinal cord injury	31683
@VP	can improve after OEC transplantation	32042
@VP	improve after OEC transplantation	32046
@VP	are the more likely clinical application	32101
